Patent · US Active

Quinazolinedione derivatives as PARP inhibitors

US9255080B2 · kind B2 · utility

0Cited by

14References

8Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Ludo Edmond Josephine Kennis · Lier, BE
Josephus Carolus Mertens · Oud-Turnhout, BE
Jacobus Alphonsus Josephus Van Dun · Kasterlee, BE
Maria Victorina Francisca Somers · Vosselaar, BE
Walter Boudewijn Leopold Wouters · Kapellen, BE

Key dates

Filing date	Dec 6, 2013
Grant date	Feb 9, 2016
Priority date	—
Expiry date	Aug 1, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)wherein R1, L1, L2, X, Y and Z have defined meanings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.